ethosuximide and trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride

ethosuximide has been researched along with trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burnham, WM; Chan, KF; Cortez, MA; Jia, Z; Snead, OC	1

Other Studies

1 other study(ies) available for ethosuximide and trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride

Article	Year
GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures. European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2 Topics: Animals; Anticholesteremic Agents; Anticonvulsants; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Absence; Ethosuximide; Female; GABA Antagonists; GABA-B Receptor Antagonists; Hippocampus; Learning Disabilities; Maze Learning; Memory Disorders; Organophosphorus Compounds; Rats; Time Factors; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride	2006

Article

Year

GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures.

European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2

Topics: Animals; Anticholesteremic Agents; Anticonvulsants; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Absence; Ethosuximide; Female; GABA Antagonists; GABA-B Receptor Antagonists; Hippocampus; Learning Disabilities; Maze Learning; Memory Disorders; Organophosphorus Compounds; Rats; Time Factors; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride

2006